A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2011
05/26/2011	WO2010019239A3 Pharmaceutical composition of n- [2,4-bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl] - 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide and administration thereof
05/26/2011	US20110125093 Latex medical articles for release of antimicrobial agents
05/26/2011	US20110125089 Hemostatic microspheres
05/26/2011	US20110124853 Conjugates and Compositions for Cellular Delivery
05/26/2011	US20110124743 Palatability enhancers and methods for enhancing palatability
05/26/2011	US20110124691 Organic Compounds
05/26/2011	US20110124600 Use of Dopamine partial agonists for treament of the restless leg syndrome and corresponding pharmaceutical preparation
05/26/2011	US20110124587 Pure Rebaudioside A
05/26/2011	US20110123702 Room temperature-curable polymers
05/26/2011	US20110123692 Crystallization of polyol compositions, crystalline polyol composition product and use thereof
05/26/2011	US20110123652 Self-emulsifying active substance formulation and use of this formulation
05/26/2011	US20110123619 Buccal delivery system
05/26/2011	US20110123608 Pharmaceutical formulation
05/26/2011	US20110123607 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
05/26/2011	US20110123601 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery
05/26/2011	US20110123592 Biomaterials
05/26/2011	US20110123577 Method Of Delivering Stable Topical Drug Compositions
05/26/2011	US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
05/26/2011	US20110123487 Therapeutic agents comprising elastic peptides
05/26/2011	US20110123473 Use of highly-branched polycarbonates in cosmetic and dermatological formulations
05/26/2011	US20110123470 Natural bioactive compounds
05/26/2011	US20110123464 Stabilization of body-care and household products
05/26/2011	US20110123448 Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
05/26/2011	US20110123446 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
05/26/2011	CA2818241A1 Methods for improving oral delivery
05/26/2011	CA2818237A1 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
05/26/2011	CA2781672A1 Polypeptide conjugate
05/26/2011	CA2781669A1 Cyclodextrin-based polymers for therapeutic delivery
05/26/2011	CA2781580A1 Topical foam composition
05/26/2011	CA2781579A1 Topical foam composition
05/26/2011	CA2781467A1 Formulations of antibody
05/26/2011	CA2781329A1 Magnetic iron oxide fine particles, and magnetic particle-containing water dispersion and process for producing the same
05/26/2011	CA2781139A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
05/26/2011	CA2781108A1 Drug-loaded fibers
05/26/2011	CA2781027A1 Method for treating retinal conditions using an intraocular tamponade
05/26/2011	CA2780779A1 Acid salt forms of polymer-drug conjugates and alkoxylation methods
05/26/2011	CA2780645A1 Salt form of a multi-arm polymer-drug conjugate
05/26/2011	CA2780554A1 Formulation for hgh and rhigf-1 combination
05/26/2011	CA2774094A1 Formulations of daptomycin
05/25/2011	EP2325631A1 Antibody conjugated to peptide via a UV cleavable linker
05/25/2011	EP2325236A1 Dendritic polymers with enhanced amplification and interior functionality
05/25/2011	EP2325210A1 Monoclonal antibodies against Claudin-18 for treatment of cancer
05/25/2011	EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
05/25/2011	EP2325193A2 Methods and compositions for therapeutic use of RNA interference
05/25/2011	EP2324863A1 Method for producing artificial skin
05/25/2011	EP2324861A1 In vivo use of water absorbent polymers
05/25/2011	EP2324855A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
05/25/2011	EP2324854A1 Drug sustained release agent, adsorbent, functional food, mask, and adsorptive sheet
05/25/2011	EP2324846A1 Use of urease for inhibiting cancer cell growth
05/25/2011	EP2324845A1 Liquid stabilized protein formulations in coated pharmaceutical containers
05/25/2011	EP2324833A1 Film preparation containing loperamide hydrochloride
05/25/2011	EP2324829A1 Therapeutic inhibitors of vascular smooth muscle cells
05/25/2011	EP2324826A1 Hydrophilic amino acid-containing preparation having improved taste
05/25/2011	EP2324812A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
05/25/2011	EP2324045A2 Photo-crosslinked nucleic acid hydrogels
05/25/2011	EP2323695A1 Complexes of small-interfering nucleic acids
05/25/2011	EP2323694A1 Conjugated proteins with prolonged in vivo efficacy
05/25/2011	EP2323693A1 Drug carriers
05/25/2011	EP2323671A1 Aabb-poly(depsipeptide) biodegradable polymers and methods of use
05/25/2011	EP2323636A1 Chelating amphiphilic polymers
05/25/2011	EP2323628A2 Carrier nanoparticles and related compositions, methods and systems
05/25/2011	EP2323623A1 Pharmaceutical compositions
05/25/2011	EP2323617A1 Hyaluronic acid-based gels including anesthetic agents
05/25/2011	EP2252284B1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
05/25/2011	EP2066705B1 Cationic polymers as thickeners for aqueous and alcoholic compositions
05/25/2011	EP2037974B1 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition
05/25/2011	EP1482912B1 Naltrexone hydrochloride compositions
05/25/2011	EP1439847B1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/25/2011	EP1335726B1 Modified prodrug forms of ap
05/25/2011	EP1294361B1 Compositions and methods to improve the oral absorption of antimicrobial agents
05/25/2011	EP1267942B1 Chemically modified novel erythropoietin stimulating protein compositions and methods
05/25/2011	EP1263463B1 Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells
05/25/2011	EP0947584B1 Loxoprofen-containing preparation for external use
05/25/2011	CN201840678U Microecological vagina stype
05/25/2011	CN201840677U Preparation structure with carbon film layer
05/25/2011	CN1730494B Cobratide modified by polyethylene glycol, its preparation method and uses
05/25/2011	CN102076362A Nicotine lozenge compositions
05/25/2011	CN102076357A Microneedle device, and method for enhancing efficacy of influenza vaccine by using microneedle devive
05/25/2011	CN102076345A Liquid composition comprising cisplatin-coordinating compound
05/25/2011	CN102076340A Transdermal patch containing fentanyl or salt thereof
05/25/2011	CN102076328A Micelles for intracellular delivery of therapeutic agents
05/25/2011	CN102076324A Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same
05/25/2011	CN102076323A Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same
05/25/2011	CN102076314A Foaming skincare cream
05/25/2011	CN102071461A Method for preparing titanium dioxide nanometer tubes and titanium dioxide nanometer tube preparation for loading enrofloxacin animal remedy
05/25/2011	CN102070992A Patch and patch preparation
05/25/2011	CN102070895A Core-shell microcapsule and preparation method thereof
05/25/2011	CN102070791A Polyvinyl alcohol crosslinked thiolated hyaluronic acid/polyvinyl alcohol film and preparation method and application thereof
05/25/2011	CN102070784A pH-responsive degradable hydrogel and preparation method thereof
05/25/2011	CN102070774A Preparation method of copolymer of monose or sugar alcohol of monose and lactic acid
05/25/2011	CN102070773A Injectable temperature-sensitive polycarbonate-polyethylene glycol segmented copolymer hydrogel
05/25/2011	CN102070772A Preparation method of solid mint type spice
05/25/2011	CN102070756A Sugar-responsive medicament delivery material and preparation method thereof
05/25/2011	CN102070135A Amphiphilic porous hollow carbon microsphere as well as preparation method and application thereof
05/25/2011	CN102068703A Doxorubicin multi-targeting drug delivery system and preparation method and application thereof
05/25/2011	CN102068702A Lactosyl-norcantharidin phospholipid compound and preparation method thereof
05/25/2011	CN102068701A Application of cleavable polyethylene glycol (PEG) lipid derivative to preparation
05/25/2011	CN102068700A Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material
05/25/2011	CN102068699A Medical pressure-sensitive adhesive composition
05/25/2011	CN102068698A Nanometer vaccine and preparation method thereof

1 ... 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 ... 1712